IL-31 plays a role in many inflammatory skin diseases, including AD and PN.1-3 IL-31 bridges the peripheral nervous system and immune system and targets structural skin cells, driving itch, inflammation, and skin abnormalities.1
IL-31 is a central mediator of neuroimmune skin dysfunction
The center of neuroimmune skin dysfunction¹
Ready to dive deeper?
Watch these videos for a closer look at the role of IL-31 in AD and PN.
The burden of disease in AD
The signs and symptoms of AD can significantly disrupt patients’ daily lives.4,5
Useful resources
IL-31 at a glance
Download this brochure for a summary of the role of IL-31 in AD and PN.
Diagnosing AD and PN
Download this guide for diagnosing AD and PN in your patients.
In a hurry?
Download this flash card to get the quick facts on PN.
The images in this material are not of actual patients with AD or PN. They were created based on informed Galderma insights. AD and PN can manifest in individuals differently.
1. Nemmer JM, Kuchner M, Datsi A, et al. Interleukin-31 signaling bridges the gap between immune cells, the nervous system and epithelial tissues. Front Med (Lausanne). 2021;8:639097. doi:10.3389/fmed.2021.639097 2. Datsi A, Steinhoff M, Ahmad F, Alam M, Buddenkotte J. Interleukin-31: the "itchy" cytokine in inflammation and therapy. Allergy. 2021;76(10):2982-2997. doi:10.1111/all.14791 3. Williams KA, Roh YS, Brown I, et al. Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis. Expert Rev Clin Pharmacol. 2021;14(1):67-77. doi:10.1080/17512433.2021.1852080 4. Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396(10247):345-360. doi:10.1016/S0140-6736(20)31286-1 5. McCleary KK. More than skin deep: understanding the lived experience of eczema. March 18, 2020. Accessed December 15, 2021. http://www.morethanskindeep-eczema.org/report.html
References: